A new trial showed three different doses of aspirin all reduce bowel cancer risk specifically in people with Lynch syndrome.

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...

The EpiSwitch PSE next generation blood test uses advances in technology to identify prostate cancer, the most common form of ...

The award reflects confidence in MetasTx’s multichannel strategy to detect and interrupt cancer metastasis. Combining pharmacologic and diagnostic innovation, MetasTx aims to transform how clinicians ...

National Cancer Prevention Month serves as a powerful reminder that we all have a role to play in reducing the risk of cancer ...

In an interview with Targeted OncologyTM, Ravi Muvner, MD, urologist at Hackensack University Medical Center, discusses how targeted therapies have changed the landscape of prostate cancer treatment.

A new urology lab with advanced diagnostic testing is up and running at UPMC St. Margaret Hospital to deal with a slow but ...

The Prostate Cancer Market is set to grow from USD 11.7 Billion in 2022 to USD 21.6 Billion by 2031, driven by rising cases in targeted therapies. The U.S. Prostate Cancer Market is expanding rapidly ...

In recognition of Men’s Health Month, the University of Virginia (UVA) Cancer Center is expanding its “Stay in the Game” program, a vital community-centered initiative dedicated ...

For men who undergo radiation therapy for prostate cancer, bowel problems are a common complication. This is due to the ...

Former President Joe Biden has been diagnosed with prostate cancer. Biden, 82, was diagnosed Friday, May 16, with prostate ...